Lion's Mane Mushroom — Expert Claims
Extracted from publicly available podcast transcripts and videos. Each claim is attributed and sourced.
Expert Consensus
Claims are extracted using AI (Claude) from publicly available transcripts, each attributed to its source with an extraction-confidence rating (high / medium / low) so it can be verified, then compared against PubMed research. See how our data is made.
136 expert mentions
“as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
As a potential cognitive support supplement, lion's mane has a favorable risk profile and a sound rationale.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain, which has much lower concentrations of active compounds.
None of the 10 studies listed directly compare bioactive compound concentrations between lion's mane fruiting body and mycelium-on-grain preparations, nor do they assess clinical outcome differences b…
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
The published RCTs listed are consistent with Huberman's stated dosage range of 500 mg to 3 g per day. PMID 38004235 used 1.8 g/day in young adults, PMID 18844328 used doses in the range consistent wi…
“as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
As a potential cognitive support supplement, lion's mane has a favorable risk profile and a sound rationale.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium; many cheaper supplements use mycelium grown on grain, which has much lower concentrations of active compounds.
None of the 10 studies in the provided list directly compare fruiting body versus mycelium preparations in terms of bioactive compound concentrations or clinical efficacy. The RCT by Mori et al. (PMID…
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
For those interested in lion's mane, the expert recommends choosing products made from the fruiting body rather than mycelium-only products, and looking for dual extracts standardized to hericenone or erinacine content.
No relevant PubMed studies were retrieved to assess this claim.
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
If interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.
The provided studies do not directly compare fruiting body vs. mycelium-only products, nor do they evaluate dual-extraction methods or standardization to hericenone/erinacine content. The RCTs (PMIDs…
“as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
As a potential cognitive support supplement, lion's mane has a favorable risk profile and a sound rationale.
No relevant PubMed studies were retrieved to assess this claim.
“Look for dual-extract products using the fruiting body.”
For lion's mane supplementation, one should look for dual-extract products using the fruiting body.
No relevant PubMed studies were retrieved to assess this claim.
“as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
As a potential cognitive support supplement, lion's mane has a favorable risk profile and a sound rationale.
No relevant PubMed studies were retrieved to assess this claim.
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
For those interested in lion's mane, the expert recommends choosing products made from the fruiting body rather than mycelium-only products, and looking for dual extracts standardized to hericenone or erinacine content.
No relevant PubMed studies were retrieved to assess this claim.
“Look for dual-extract products using the fruiting body.”
For lion's mane supplementation, one should look for dual-extract products using the fruiting body.
No relevant PubMed studies were retrieved to assess this claim.
“as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
As a potential cognitive support supplement, lion's mane has a favorable risk profile and a sound rationale.
Multiple RCTs provide some support for lion's mane as a cognitive supplement: PMID 18844328 found improvements in a cognitive function scale in 50–80-year-old Japanese adults with mild cognitive impai…
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
For those interested in lion's mane, the expert recommends choosing products made from the fruiting body rather than mycelium-only products, and looking for dual extracts standardized to hericenone or erinacine content.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition, but as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
Lion's mane is not recommended as a treatment for any diagnosed condition, but as a potential cognitive support supplement the risk profile appears favorable and the rationale is sound.
The expert's claim that lion's mane is not a treatment for diagnosed conditions but may serve as a cognitive support supplement with a favorable risk profile and sound rationale is broadly consistent…
“Look for dual-extract products using the fruiting body.”
For lion's mane supplementation, one should look for dual-extract products using the fruiting body.
None of the 10 studies provided directly evaluate or compare dual-extract products versus single-extract, or fruiting body versus mycelium formulations in terms of cognitive or mood outcomes in humans…
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
For those interested in lion's mane, the expert recommends choosing products made from the fruiting body rather than mycelium-only products, and looking for dual extracts standardized to hericenone or erinacine content.
None of the 10 studies in the provided literature directly compare fruiting body versus mycelium-only products, nor do any evaluate the clinical relevance of standardizing lion's mane supplements to s…
“choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content”
Choose lion's mane products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.
None of the 10 studies provided directly compare fruiting body versus mycelium-only products, nor do any evaluate standardization to hericenone or erinacine content as a quality marker in humans. The…
“Look for dual-extract products using the fruiting body.”
For lion's mane supplementation, one should look for dual-extract products using the fruiting body.
No relevant PubMed studies were retrieved to assess this claim.
“if you're interested in lion's mane, choose products made from the fruiting body rather than mycelium-only products, and look for dual extracts standardized to hericenone or erinacine content.”
For those interested in lion's mane, the expert recommends choosing products made from the fruiting body rather than mycelium-only products, and looking for dual extracts standardized to hericenone or erinacine content.
No relevant PubMed studies were retrieved to assess this claim.
“Look for dual-extract products using the fruiting body.”
For lion's mane supplementation, one should look for dual-extract products using the fruiting body.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition, but as a potential cognitive support supplement, the risk profile appears favorable and the rationale is sound.”
Lion's mane is not recommended as a treatment for any diagnosed condition, but as a potential cognitive support supplement its risk profile appears favorable and the rationale is sound.
The expert's claim has two components: (1) lion's mane is not recommended as a treatment for diagnosed conditions, and (2) its risk profile is favorable and rationale as a cognitive support supplement…
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study in healthy adults showed improvements in short-term memory and attention with lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
Cognitive scores declined toward baseline after stopping lion's mane supplementation, suggesting the effect was real but required continued use.
The RCT by Mori et al. (PMID 18844328) directly supports this claim: it was a double-blind, placebo-controlled trial in 50-80 year-old Japanese adults with mild cognitive impairment that found cogniti…
“The human evidence that I find most relevant is the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.”
A Japanese randomized controlled trial by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
No relevant PubMed studies were retrieved to assess this claim.
“The human evidence that I find most relevant is the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.”
A Japanese randomized controlled trial by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
No relevant PubMed studies were retrieved to assess this claim.
“there's a small trial showing reduction in depression and anxiety in overweight adults taking lion's mane”
A small trial showed reduction in depression and anxiety in overweight adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal models, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease.
Huberman's claim specifically concerns animal model evidence for lion's mane improving memory, reducing anxiety, stimulating hippocampal neurogenesis, and showing neuroprotective effects in Alzheimer'…
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study with healthy adults showed improvements in short-term memory and attention from lion's mane supplementation.
The RCT by PMID 38004235 (double-blind, parallel-groups pilot study, 28-day intervention, 1.8g dose) investigated cognitive and mood effects in young adults and found improvements following lion's man…
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease.
The expert's claim specifically concerns animal studies showing memory improvement, anxiety reduction, hippocampal neurogenesis, and neuroprotective effects in Alzheimer's models. The provided literat…
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
The available studies directly corroborate Huberman's claim about the dosage range. The RCT by PMID 38004235 used 1.8 g/day, PMID 31413233 used an oral supplement over 12 weeks, and PMID 18844328 stud…
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease in mice.
No relevant PubMed studies were retrieved to assess this claim.
“The human evidence that I find most relevant is the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.”
A Japanese randomized controlled trial by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
PMID 18844328 directly corresponds to the Mori et al. RCT referenced by the expert — a double-blind, placebo-controlled trial in Japanese adults (ages 50–80) diagnosed with mild cognitive impairment u…
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
In the Mori et al. trial, cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
The Mori et al. trial (PMID: 18844328) is directly referenced in the provided literature as a double-blind, placebo-controlled RCT in 50-80 year-old Japanese adults with mild cognitive impairment. The…
“there's a small trial showing reduction in depression and anxiety in overweight adults taking lion's mane”
A small trial showed reduction in depression and anxiety in overweight adults taking lion's mane.
None of the 10 studies listed above directly investigate lion's mane supplementation for depression and anxiety in overweight adults specifically. While PMID 38004235 examined mood effects in young ad…
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease in mice.
Huberman's claim specifically references animal (mouse) studies showing memory improvement, anxiety reduction, hippocampal neurogenesis, and Alzheimer's model neuroprotection. None of the 10 provided…
“There's a notable Japanese trial from 2009 with 30 patients with mild cognitive impairment who showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.”
A 2009 Japanese trial with 30 patients with mild cognitive impairment showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.
PMID 18844328 directly corresponds to the trial Huberman describes: a double-blind, placebo-controlled study in 50-80 year old Japanese individuals with mild cognitive impairment using Hericium erinac…
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study in healthy adults showed improvements in short-term memory and attention with lion's mane.
The RCT by Jurgens et al. (PMID: 38004235) directly examined cognitive effects including attention in healthy young adults over 28 days, finding some acute cognitive benefits following a single dose o…
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed reduced depression and anxiety in overweight or obese adults taking lion's mane.
None of the 10 studies provided specifically examine depression and anxiety outcomes in overweight or obese adults taking lion's mane. The available RCTs (PMIDs 38004235, 31413233, 18844328, 38140277)…
“the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation”
A Japanese RCT by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
PMID 18844328 is a double-blind, placebo-controlled RCT involving Japanese adults aged 50–80 with mild cognitive impairment that directly matches the expert's description of a Mori et al. study showin…
“scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use”
Cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
The classic RCT on mild cognitive impairment (PMID: 18844328) is the most directly relevant study, as it examined Hericium erinaceus over a defined intervention period in 50-80 year old Japanese adult…
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease in mice.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed that lion's mane reduced depression and anxiety in overweight or obese adults.
None of the 10 listed studies specifically examined lion's mane supplementation in overweight or obese adults measuring depression and anxiety outcomes. The closest human RCTs (PMIDs 38004235, 3141323…
“There's a notable Japanese trial from 2009 with 30 patients with mild cognitive impairment who showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.”
A 2009 Japanese trial with 30 patients with mild cognitive impairment showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed reduced depression and anxiety in overweight or obese adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study in healthy adults showed improvements in short-term memory and attention with lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
No relevant PubMed studies were retrieved to assess this claim.
“there's a small trial showing reduction in depression and anxiety in overweight adults taking lion's mane”
A small trial showed reduction in depression and anxiety in overweight adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
No relevant PubMed studies were retrieved to assess this claim.
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study in healthy adults showed improvements in short-term memory and attention with lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed reduced depression and anxiety in overweight or obese adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
In the Mori et al. trial, cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
No relevant PubMed studies were retrieved to assess this claim.
“there's a small trial showing reduction in depression and anxiety in overweight adults taking lion's mane”
A small trial showed reduction in depression and anxiety in overweight adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“The human evidence that I find most relevant is the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.”
A Japanese randomized controlled trial by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed lion's mane reduced depression and anxiety in overweight or obese adults.
None of the 10 listed studies specifically examined lion's mane supplementation in overweight or obese adults for depression and anxiety outcomes. The closest relevant studies (PMIDs 38004235 and 3141…
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
In the Mori et al. trial, cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
No relevant PubMed studies were retrieved to assess this claim.
“There's a notable Japanese trial from 2009 with 30 patients with mild cognitive impairment who showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.”
A 2009 Japanese trial with 30 patients with mild cognitive impairment showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.
No relevant PubMed studies were retrieved to assess this claim.
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study with healthy adults showed improvements in short-term memory and attention from lion's mane.
The RCT by Saitsu et al. (PMID: 31413233) tested Hericium erinaceus supplementation for 12 weeks in a double-blind, placebo-controlled design and found improvements in cognitive functions, providing s…
“The human evidence that I find most relevant is the Japanese randomized controlled trial by Mori and colleagues showing significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.”
A Japanese randomized controlled trial by Mori and colleagues showed significant improvement in cognitive function scores in adults with mild cognitive impairment after 16 weeks of lion's mane supplementation.
No relevant PubMed studies were retrieved to assess this claim.
“A follow-up study with healthy adults showed improvements in short-term memory and attention.”
A follow-up study in healthy adults showed improvements in short-term memory and attention with lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
No relevant PubMed studies were retrieved to assess this claim.
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease in mice.
No relevant PubMed studies were retrieved to assess this claim.
“There's a notable Japanese trial from 2009 with 30 patients with mild cognitive impairment who showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.”
A 2009 Japanese trial with 30 patients with mild cognitive impairment showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.
No relevant PubMed studies were retrieved to assess this claim.
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
In the Mori et al. trial, cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed reduced depression and anxiety in overweight or obese adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“there's a small trial showing reduction in depression and anxiety in overweight adults taking lion's mane”
A small trial showed reduction in depression and anxiety in overweight adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“There's a notable Japanese trial from 2009 with 30 patients with mild cognitive impairment who showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.”
A 2009 Japanese trial with 30 patients with mild cognitive impairment showed significant improvement in cognitive scores after 16 weeks of lion's mane supplementation, with decline after stopping.
No relevant PubMed studies were retrieved to assess this claim.
“Typical doses in trials range from 500 milligrams to 3 grams per day.”
Typical doses of lion's mane used in trials range from 500 milligrams to 3 grams per day.
No relevant PubMed studies were retrieved to assess this claim.
“In mice, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and even shown neuroprotective effects in models of Alzheimer's disease.”
In animal studies, lion's mane has improved memory, reduced anxiety-like behavior, stimulated hippocampal neurogenesis, and shown neuroprotective effects in models of Alzheimer's disease in mice.
No relevant PubMed studies were retrieved to assess this claim.
“There's also a small trial showing reduced depression and anxiety in overweight or obese adults.”
A small trial showed reduced depression and anxiety in overweight or obese adults taking lion's mane.
No relevant PubMed studies were retrieved to assess this claim.
“Importantly, scores declined toward baseline after stopping the supplement, suggesting the effect was real but required continued use.”
In the Mori et al. trial, cognitive scores declined toward baseline after stopping lion's mane, suggesting the effect was real but required continued use.
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease.”
Nerve growth factor is critical for the survival and function of cholinergic neurons, which are the type of neuron preferentially lost in Alzheimer's disease.
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease.”
Nerve growth factor is critical for the survival and function of cholinergic neurons, which are the type of neuron preferentially lost in Alzheimer's disease.
No relevant PubMed studies were retrieved to assess this claim.
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF, which lion's mane may stimulate, are proteins that promote the survival, growth, and maintenance of neurons, making anything that raises BDNF extremely interesting from a cognitive and mental health perspective.
No relevant PubMed studies were retrieved to assess this claim.
“The active compounds — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.”
The active compounds in lion's mane — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.
The expert's mechanistic claim about hericenones and erinacines stimulating nerve growth factor (NGF) production is consistent with the broader scientific literature on lion's mane, and is implicitly…
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
Potential mechanisms for lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
The mechanistic claims about anti-inflammatory properties are supported indirectly: the systematic review (PMID: 40289452) notes that EMFs including Hericium erinaceus modulate neurotransmitter system…
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
Lion's mane mushroom contains hericenones and erinacines, which in cell culture and animal models have been shown to stimulate production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease.”
Nerve growth factor is critical for the survival and function of cholinergic neurons, which are the type of neuron preferentially lost in Alzheimer's disease.
No relevant PubMed studies were retrieved to assess this claim.
“The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.
The expert's claim about NGF (nerve growth factor) stimulation being a compelling mechanistic basis for neuroprotection is conceptually supported by several reviews in the literature. The mechanistic…
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
The potential mechanisms behind lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
No relevant PubMed studies were retrieved to assess this claim.
“The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.
No relevant PubMed studies were retrieved to assess this claim.
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
Lion's mane mushroom contains hericenones and erinacines, which in cell culture and animal models have been shown to stimulate production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
No relevant PubMed studies were retrieved to assess this claim.
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
The potential mechanisms behind lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
No relevant PubMed studies were retrieved to assess this claim.
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
The potential mechanisms behind lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
No relevant PubMed studies were retrieved to assess this claim.
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
The potential mechanisms behind lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
The systematic review (PMID: 40289452, rated strong quality) directly supports the anti-inflammatory mechanism, noting that edible medicinal fungi including Hericium erinaceus modulate neurotransmitte…
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
Lion's mane mushroom contains hericenones and erinacines, which in cell culture and animal models have been shown to stimulate production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
The expert's claim that lion's mane contains hericenones and erinacines that stimulate NGF and BDNF production in cell culture and animal models is consistent with the mechanistic framework described…
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF, which lion's mane may stimulate, are proteins that promote the survival, growth, and maintenance of neurons, making anything that raises BDNF extremely interesting from a cognitive and mental health perspective.
The mechanistic claim that NGF and BDNF promote neuron survival, growth, and maintenance is well-established neuroscience and not contested by any study here. However, Huberman's specific claim that l…
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF, which lion's mane may stimulate, are proteins that promote the survival, growth, and maintenance of neurons, making anything that raises BDNF extremely interesting from a cognitive and mental health perspective.
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease.”
Nerve growth factor is critical for the survival and function of cholinergic neurons, which are the type of neuron preferentially lost in Alzheimer's disease.
No relevant PubMed studies were retrieved to assess this claim.
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF, which lion's mane may stimulate, are proteins that promote the survival, growth, and maintenance of neurons, making anything that raises BDNF extremely interesting from a cognitive and mental health perspective.
No relevant PubMed studies were retrieved to assess this claim.
“The active compounds — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.”
The active compounds in lion's mane — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.
No relevant PubMed studies were retrieved to assess this claim.
“hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production”
Hericenones from the fruiting body and erinacines from the mycelium have been shown in cell and animal studies to stimulate nerve growth factor production.
The expert's mechanistic claim about hericenones and erinacines stimulating nerve growth factor (NGF) production in cell and animal studies is biologically plausible and consistent with the mechanisti…
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
Lion's mane mushroom contains hericenones and erinacines, which in cell culture and animal models have been shown to stimulate production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
No relevant PubMed studies were retrieved to assess this claim.
“The active compounds — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.”
The active compounds in lion's mane — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease. The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
Nerve growth factor is critical for the survival and function of cholinergic neurons — the type preferentially lost in Alzheimer's disease — making NGF stimulation compelling from a neuroprotection standpoint.
The expert's claim is a mechanistic statement about NGF's role in cholinergic neuron survival and its relevance to Alzheimer's disease neuroprotection. The provided studies (PMID 18844328, 31413233, 3…
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF, which lion's mane may stimulate, are proteins that promote the survival, growth, and maintenance of neurons, making anything that raises BDNF extremely interesting from a cognitive and mental health perspective.
No relevant PubMed studies were retrieved to assess this claim.
“The potential mechanisms include reducing inflammatory cytokines and potentially influencing the gut-brain axis.”
The potential mechanisms behind lion's mane's psychiatric effects include reducing inflammatory cytokines and potentially influencing the gut-brain axis.
No relevant PubMed studies were retrieved to assess this claim.
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
The key compounds in lion's mane — hericenones and erinacines — have been shown in cell culture and animal models to stimulate the production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
The expert's claim about hericenones and erinacines stimulating NGF and BDNF production in cell culture and animal models is consistent with the mechanistic background described across several reviews…
“The active compounds — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.”
The active compounds in lion's mane — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.
No relevant PubMed studies were retrieved to assess this claim.
“The active compounds — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.”
The active compounds in lion's mane — hericenones from the fruiting body and erinacines from the mycelium — have been shown in cell and animal studies to stimulate nerve growth factor production.
No relevant PubMed studies were retrieved to assess this claim.
“The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.
No relevant PubMed studies were retrieved to assess this claim.
“Nerve growth factor, or NGF, is critical for the survival and function of cholinergic neurons — the type of neuron that's preferentially lost in Alzheimer's disease.”
Nerve growth factor is critical for the survival and function of cholinergic neurons, which are the type of neuron preferentially lost in Alzheimer's disease.
The expert's claim is a well-established neuroscientific mechanism — that nerve growth factor (NGF) supports cholinergic neuron survival and that these neurons are preferentially lost in Alzheimer's d…
“The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.
No relevant PubMed studies were retrieved to assess this claim.
“NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons. Anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.”
NGF and BDNF are proteins that promote the survival, growth, and maintenance of neurons, and anything that raises BDNF is extremely interesting from a cognitive and mental health perspective.
The claim that NGF and BDNF promote neuronal survival, growth, and maintenance is well-established neuroscience consistent with the mechanistic background cited in multiple reviews (PMIDs 32663897, 39…
“The key compounds in lion's mane are hericenones and erinacines, which in cell culture and animal models have been shown to stimulate the production of nerve growth factor — NGF — and brain-derived neurotrophic factor — BDNF.”
Lion's mane mushroom contains hericenones and erinacines, which in cell culture and animal models have been shown to stimulate production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).
No relevant PubMed studies were retrieved to assess this claim.
“The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.”
The idea that a natural compound could stimulate NGF production in the brain is genuinely compelling from a neuroprotection standpoint.
No relevant PubMed studies were retrieved to assess this claim.
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, so larger and more rigorous trials are needed before making strong recommendations.
The available evidence directly supports Huberman's caution. The human RCTs identified (PMIDs 18844328, 31413233, 38004235, 38140277) are small pilot or single-center studies, with the oldest landmark…
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around the supplement; most human trials are small, short, and from a limited set of research groups.
No relevant PubMed studies were retrieved to assess this claim.
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well known.
No relevant PubMed studies were retrieved to assess this claim.
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around the supplement; most human trials are small, short, and from a limited set of research groups.
No relevant PubMed studies were retrieved to assess this claim.
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, and larger, more rigorous trials are needed before making strong recommendations.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain which has much lower concentrations of active compounds.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition”
The expert does not recommend lion's mane as a treatment for any diagnosed condition.
No relevant PubMed studies were retrieved to assess this claim.
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, and larger, more rigorous trials are needed before making strong recommendations.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain which has much lower concentrations of active compounds.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition”
The expert does not recommend lion's mane as a treatment for any diagnosed condition.
No relevant PubMed studies were retrieved to assess this claim.
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around the supplement; most human trials are small, short, and from a limited set of research groups.
No relevant PubMed studies were retrieved to assess this claim.
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well known.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition”
The expert does not recommend lion's mane as a treatment for any diagnosed condition.
No relevant PubMed studies were retrieved to assess this claim.
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, and larger, more rigorous trials are needed before making strong recommendations.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain which has much lower concentrations of active compounds.
No relevant PubMed studies were retrieved to assess this claim.
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around the supplement; most human trials are small, short, and from a limited set of research groups.
No relevant PubMed studies were retrieved to assess this claim.
“I don't recommend it as a treatment for any diagnosed condition”
The expert does not recommend lion's mane as a treatment for any diagnosed condition.
No relevant PubMed studies were retrieved to assess this claim.
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well known.
No relevant PubMed studies were retrieved to assess this claim.
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain which has much lower concentrations of active compounds.
No relevant PubMed studies were retrieved to assess this claim.
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, and larger, more rigorous trials are needed before making strong recommendations.
No relevant PubMed studies were retrieved to assess this claim.
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well known.
The body of evidence provided consists largely of small pilot RCTs and reviews that use varying doses and formulations (e.g., 1.8 g in PMID 38004235, 650 mg extract in PMID 38140277, and fruiting body…
“I don't recommend it as a treatment for any diagnosed condition”
The expert does not recommend lion's mane as a treatment for any diagnosed condition.
The expert's cautious stance against recommending lion's mane as a treatment for diagnosed conditions is well-supported by the overall body of evidence presented. While several RCTs (PMIDs 18844328, 3…
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials on lion's mane are small, short, and from a limited number of research groups, so larger, more rigorous trials are needed before making strong recommendations.
The available evidence directly supports Huberman's caution. The human RCTs presented (PMIDs 18844328, 31413233, 38004235, 38140277) are individually small pilot or limited-participant trials, and the…
“The bioactive compounds are concentrated in the fruiting body, not the mycelium. Many cheaper supplements are mycelium grown on grain, which has much lower concentrations of active compounds.”
The bioactive compounds in lion's mane are concentrated in the fruiting body, not the mycelium, and many cheaper supplements use mycelium grown on grain which has much lower concentrations of active compounds.
None of the 10 studies provided directly compare fruiting body versus mycelium preparations or address the specific claim about grain-grown mycelium having lower concentrations of active compounds. Th…
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well established.
The available research directly supports the expert's caution. The studies provided use varying doses (e.g., 1.8 g in PMID 38004235, doses used in PMID 18844328 and 31413233), different preparations (…
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around the supplement; most human trials are small, short, and from a limited set of research groups.
The evidence base presented here is consistent with Tracey Marks' caution. The human RCTs available (PMIDs 18844328, 31413233, 38004235, 38140277) are small pilot or preliminary studies, with the land…
“The challenge is that most human trials are small, short, and from a limited number of research groups. We need larger, more rigorous trials before making strong recommendations.”
Most human trials of lion's mane are small, short, and from a limited number of research groups, and larger, more rigorous trials are needed before making strong recommendations.
The body of evidence provided directly supports Huberman's cautionary claim. The human RCTs identified (PMIDs 18844328, 31413233, 38004235, 38140277) are small pilot or parallel-group trials, and the…
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups.”
The research base for lion's mane is thin relative to the enthusiasm around it; most human trials are small, short, and from a limited set of research groups.
The evidence base provided directly supports Tracey Marks's caution. The human RCTs on cognitive function (PMIDs 18844328, 31413233, 38004235, 38140277) are small pilot or limited-participant trials,…
“the research base is thin relative to the enthusiasm around this supplement. Most human trials are small, short, and from a limited set of research groups. We don't know the optimal dose, the best form, or long-term safety profile well.”
The research base for lion's mane is thin relative to the enthusiasm; most human trials are small, short, and from a limited set of research groups, and optimal dose, best form, and long-term safety profile are not well known.
The evidence base presented here directly illustrates the expert's caution. The human RCTs (PMIDs 31413233, 38004235, 18844328, 38140277) are small pilot or single-center trials with short durations (…
“We don't know the optimal dose, the best form, or long-term safety profile well.”
The optimal dose, best form, and long-term safety profile of lion's mane are not well known.
No relevant PubMed studies were retrieved to assess this claim.